DIABETES MELLITUS 2ND TYPE WITH CARDIOVASCULAR AUTONOMIC NEUROPATHY

by V. A. Serhiyenko, A. A. Serhiyenko
Published 2015-09-01

Diabetic cardiomyopathy: epidemiology, etiology and pathogenesis

by V.A. Serhiyenko, A.A. Serhiyenko
Published 2020-05-01

Diabetic cardiomyopathy: diagnostic biomarkers

by V.A. Serhiyenko, A.A. Serhiyenko
Published 2020-09-01

Diabetes mellitus and acute coronary syndromes

by V.A. Serhiyenko, A.A. Serhiyenko
Published 2021-06-01

Diabetes mellitus and chronic coronary syndrome

by V.A. Serhiyenko, A.A. Serhiyenko
Published 2021-03-01

Diabetic cardiomyopathy: treatment

by A.A. Serhiyenko, V.A. Serhiyenko
Published 2020-11-01

Diabetic cardiomyopathy: classification, instrumental diagnostic methods

by A.A. Serhiyenko, V.A. Serhiyenko
Published 2020-10-01

Comparison of efficiency of omega-3 polyunsaturated fatty acids, statins and their combination on lipids parameters, vascular-thrombocyte homeostasis and heart rate variability par...

by V.A. Serhiyenko, S. Azhmi, A.A. Serhiyenko
Published 2017-08-01

EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS ON THE CIRCADIAN RHYTHM OF HEART RATE VARIABILITY PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CARDIOVASCULAR AUTONOMIC N...

by V. A. Serhiyenko, V. B. Segin, A. A. Serhiyenko
Published 2018-06-01

The potential role of benfotiamine in the treatment of diabetic cardiac autonomic neuropathy

by V.A. Serhiyenko, V.B. Segin, L.M. Serhiyenko, A.A. Serhiyenko
Published 2020-04-01

Effects of benfotiamine on the insulin resistance state, some pro- and anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy

by V. A. Serhiyenko, A. A. Serhiyenko, V. B. Segin, S. Azhmi, L. M. Serhiyenko
Published 2019-05-01